PFENEX INC (PFNX) Covered Calls

Pfenex Inc is a clinical-stage biotechnology company engaged in the development of difficult to manufacture and high-value proteins, initially focused on biosimilar therapeutics, or biosimilars.

You can sell covered calls on PFENEX INC to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for PFNX (prices last updated Mon 4:16 PM ET):

PFENEX INC (PFNX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
4.46 -0.03 3.90 5.11 45K - 0.1B
Covered Calls For PFENEX INC (PFNX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 5 0.00 5.11 -2.2% -30.9%
Dec 21 5 0.05 5.06 -1.2% -7.2%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

PfĂȘnex, Inc. is a clinical-stage biotechnology company, which engages in the development of difficult to manufacture and high-value proteins, initially focused on biosimilar therapeutics, or biosimilars. The company's product candidate is PF582, a biosimilar candidate to Lucentis (ranibizumab). It is currently conducting a Phase 1b/2a trial in patients with wet agerelated macular degeneration, or wet AMD. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.